Inogen Inc — Director's Dealing 2022

Mar 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2022-03-22

Reporting Person: Ladone Mary Kay (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-22	Common Stock	A	459	$0.00	Acquired	459	Direct

Footnotes

F1: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) May 10, 2022, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule.